A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Gastroenterology

• Publication date

  2013-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/j.gastro.2013.03.051PMID 23567350
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis.

  2013cited by this paper
• Hepatocellular carcinoma

  2012cited by this paper
• EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.

  2012cited by this paper
• Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.

  2012cited by this paper
• EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer

  2012cited by this paper
• EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.

  2012cited by this paper
• Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival.

  2012cited by this paper
• Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways

  2011cited by this paper
• Genetics of Hepatobiliary Carcinogenesis

  2011cited by this paper
• Adjuvant Therapy after Curative Treatment for Hepatocellular Carcinoma

  2011cited by this paper
• Hepatocellular carcinoma.

  2011cited by this paper
• Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma.

  2011cited by this paper
• Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma.

  2011cited by this paper
• A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients.

  2010cited by this paper
• New Strategies in Hepatocellular Carcinoma: Genomic Prognostic Markers

  2010cited by this paper
• Does Surgical Resection Have a Role in the Treatment of Large or Multinodular Hepatocellular Carcinoma?

  2010cited by this paper
• A Seven-Gene Set Associated with Chronic Hypoxia of Prognostic Importance in Hepatocellular Carcinoma

  2010cited by this paper
• Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.

  2010cited by this paper
• A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma.

  2009cited by this paper
• Clinical application of the 70-gene profile: the MINDACT trial.

  2008cited by this paper
• Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma.

  2008cited by this paper
• Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

  2008cited by this paper
• Evaluating Prediction Rules for t-Year Survivors With Censored Regression Models

  2007cited by this paper
• Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets

  2007cited by this paper
• The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin

  2006cited by this paper
• A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells

  2006influential reference
• REporting recommendations for tumor MARKer prognostic studies (REMARK)

  2005cited by this paper
• Adrenomedullin and tumour angiogenesis

  2005cited by this paper
• Can clinically localized prostate cancer be managed conservatively?

  2005cited by this paper
• LIVER FAILURE AND LIVER DISEASE

  2005cited by this paper
• REporting recommendations for tumor MARKer prognostic studies (REMARK).

  2005cited by this paper
• Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling

  2004cited by this paper
• Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.

  2003cited by this paper
• Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.

  2000cited by this paper
• Terminology of nodular hepatocellular lesions

  1995cited by this paper
• Terminology of nodular hepatocellular lesions.

  1995cited by this paper
• Hepatocellular carcinoma.

  1986cited by this paper

• Utility of tumor and non-tumor biopsies during percutaneous radiofrequency ablation for hepatocellular carcinoma

  2025cites this paper
• TP53 Mutation Predicts Worse Survival and Earlier Local Progression in Patients with Hepatocellular Carcinoma Treated with Transarterial Embolization

  2025cites this paper
• H3K36me3‐Guided m6A Modification of Oncogenic L1CAM‐AS1 Drives Macrophage Polarization and Immunotherapy Resistance in Hepatocellular Carcinoma

  2025cites this paper
• Validation of Two Prognostic Gene Scores in Patients Undergoing Liver Resection for Hepatocellular Carcinoma

  2025influential citation
• Noninvasive prediction of Glypican-3 expression in hepatocellular carcinoma using Habitat-based and peritumoral CT radiomics: a nomogram approach

  2025cites this paper
• The Search for Prognostic Biomarkers in Patients with Surgically Treated Hepatocellular Carcinoma.

  2025cites this paper
• Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments

  2024cites this paper
• Deciphering the Molecular Complexity of Hepatocellular Carcinoma: Unveiling Novel Biomarkers and Therapeutic Targets Through Advanced Bioinformatics Analysis

  2024cites this paper
• Integrated GMPS and RAMP3 as a signature to predict prognosis and immune heterogeneity in hepatocellular carcinoma.

  2024cites this paper
• Pattern‐centric transformation of omics data grounded on discriminative gene associations aids predictive tasks in TCGA while ensuring interpretability

  2024cites this paper
• Navigating the Landscape of Liver Cancer Management: Study Designs in Clinical Trials and Clinical Practices.

  2024cites this paper
• shinyDeepDR: A user-friendly R Shiny app for predicting anti-cancer drug response using deep learning

  2024cites this paper
• Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell response

  2024cites this paper
• Prognostic genomic alterations in patients undergoing liver resection for hepatocellular carcinoma

  2024cites this paper
• Upfront multi‐bipolar radiofrequency ablation for HCC in transplant‐eligible cirrhotic patients with salvage transplantation in case of recurrence

  2024cites this paper
• Role of hematological and neurological expressed 1 (HN1) in Human Cancers.

  2024cites this paper
• HN1-mediated activation of lipogenesis through Akt-SREBP signaling promotes hepatocellular carcinoma cell proliferation and metastasis

  2024cites this paper
• A transcriptomic intratumor heterogeneity-free signature overcomes sampling bias in prognostic risk classification for hepatocellular carcinoma

  2023cites this paper
• Imaging prognostication and tumor biology in hepatocellular carcinoma

  2023cites this paper
• Inflammation-related prognostic markers in resected hepatocellular carcinoma

  2023cites this paper
• Chimerization of the Anti-Viral CD8+ T Cell Response with A Broad Anti-Tumor T Cell Response Reverses Inhibition of Checkpoint Blockade Therapy by Oncolytic Virotherapy

  2023cites this paper
• Comprehensive analysis of diverse programmed cell death patterns in the prognosis, tumor microenvironment and drug sensitivity in hepatocellular carcinoma

  2023cites this paper
• Indolent cancer and pattern of progression: Two missing parameters in trial design for hepatology

  2023cites this paper
• Hepatocellular Carcinoma Genetic Classification

  2023cites this paper
• Construction and Analysis of Hepatocellular Carcinoma Prognostic Model Based on Random Forest

  2023cites this paper
• Pattern-centric transformation of omics-data sources grounded on multi-wise gene associations aids predictive tasks in TCGA while ensuring interpretability

  2023cites this paper
• A transcriptomic intratumour heterogeneity-free signature overcomes sampling bias in prognostic risk classification for hepatocellular carcinoma

  2023cites this paper
• Management of hepatocellular carcinoma recurrence after liver surgery and thermal ablations: state of the art and future perspectives

  2023cites this paper
• Tumour stemness and poor clinical outcomes in haemochromatosis patients with hepatocellular carcinoma

  2023influential citation
• Enhancement of treatment efficacy of hepatic tumours using Trans-arterial-chemoembolization.

  2023cites this paper
• ERS: A simple scoring system to predict early recurrence after surgical resection for hepatocellular carcinoma

  2023cites this paper
• Impact of WTAP in small HCC and paired adjacent non-neoplastic liver tissue on recurrence: A cohort study with external extension analysis

  2022cites this paper
• Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models

  2022cites this paper
• Global research status and frontiers on microvascular invasion of hepatocellular carcinoma: A bibliometric and visualized analysis

  2022cites this paper
• CHRIST: CD44-Incorporated Hepatocellular Carcinoma Risk Index Scoring Tool—A Novel Prognostic Scoring System for Hepatocellular Carcinoma Development and Aggressiveness

  2022cites this paper
• Prolonged Survival after Recurrence in HCC Resected Patients Using Repeated Curative Therapies: Never Give Up!

  2022cites this paper
• Pathogenesis to management of hepatocellular carcinoma

  2022cites this paper
• Multi-region sequencing with spatial information enables accurate heterogeneity estimation and risk stratification in liver cancer

  2022cites this paper
• Development and validation of an eight-gene signature based predictive model to evaluate the prognosis of hepatocellular carcinoma patients: a bioinformatic study

  2022cites this paper
• Etiology, Pathogenesis, Diagnosis, and Practical Implications of Hepatocellular Neoplasms

  2022cites this paper
• Metabolism-Related Gene Pairs to Predict the Clinical Outcome and Molecular Characteristics of Early Hepatocellular Carcinoma

  2022cites this paper
• Hepatocellular Carcinoma: The Role of MicroRNAs

  2022cites this paper
• Deep View of HCC Gene Expression Signatures and Their Comparison with Other Cancers

  2022cites this paper
• Traitement du carcinome hépatocellulaire

  2021cites this paper
• Identification of a Cancer Stemness Driven Prognostic Model and Therapeutic Drug Targets by Machine Learning in Hepatocellular Carcinoma

  2021cites this paper
• Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma

  2021cites this paper
• Comprehensive Analysis of The Expression and Prognosis For KRTs in LUSC Based on Bioinformatics Analysis

  2021cites this paper
• Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies.

  2021cites this paper
• Nomogram for Prediction of Hepatocellular Carcinoma Prognosis

  2021cites this paper
• An Overview of the Genomic Characterization of Hepatocellular Carcinoma

  2021cites this paper
• Clinicopathological assessment of steatohepatitic hepatocellular carcinoma.

  2021cites this paper
• Prognostic Value of the Preoperative Lymphocyte-C-Reactive Protein Ratio in Hepatocellular Carcinoma Patients Treated with Curative Intent: A Large-Scale Multicentre Study

  2021cites this paper
• Cooperation Between the NRF2 Pathway and Oncogenic β‐catenin During HCC Tumorigenesis

  2021cites this paper
• The Endless Sources of Hepatocellular Carcinoma Heterogeneity

  2021cites this paper
• Combined hepatocellular-cholangiocarcinoma: An update.

  2021cites this paper
• Prognostic Cancer Gene Expression Signatures: Current Status and Challenges

  2021cites this paper
• Long Noncoding RNA NIHCOLE Promotes Ligation Efficiency of DNA Double-Strand Breaks in Hepatocellular Carcinoma

  2021cites this paper
• Multi-Institutional Development and External Validation of a Nomogram for Prediction of Extrahepatic Recurrence After Curative-Intent Resection for Hepatocellular Carcinoma

  2021cites this paper
• Diagnosis and treatment of hepatocellular carcinoma. Update of the consensus document of the AEEH, AEC, SEOM, SERAM, SERVEI, and SETH

  2021cites this paper
• Prognostic significance of KRT19 in Lung Squamous Cancer

  2021cites this paper
• Expression of NKG2D ligands is downregulated by beta-catenin signaling and associates with HCC aggressiveness.

  2021cites this paper
• Diagnosis and treatment of hepatocellular carcinoma. Update of the consensus document of the AEEH, AEC, SEOM, SERAM, SERVEI, and SETH.

  2021cites this paper
• Molecular classification of hepatocellular carcinoma: prognostic importance and clinical applications

  2021cites this paper
• International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma.

  2021cites this paper
• TMEM88 is a Prognostic Biomarker and Correlates With Immune Infiltrates in Hepatocellular Carcinoma

  2021cites this paper
• BAP1 mutations define a specific subgroup of hepatocellular carcinoma with fibrolamellar features and PKA activation Short title: BAP1 HCC have FLC features and activate PKA

  2020influential citation
• TERT Promoter Mutation in Serum Cell-Free DNA Is a Diagnostic Marker of Primary Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease.

  2020cites this paper
• Hepatocellular Carcinoma: Role of Pathology in the Era of Precision Medicine.

  2020cites this paper
• Trends in Tumor Indices in Relation to Increased Hepatocellular Carcinoma Size: Evidence for Tumor Evolution as a Function of Growth

  2020cites this paper
• Biomarkers for hepatocellular cancer

  2020cites this paper
• Identification of Key Genes in HCV-induced HCC at Early Stage on the Background of HCV-cirrhosis

  2020cites this paper
• Gene Expression and Polymorphism in Diagnosis of Hepatocellular Carcinoma in HCV-Infected Patients

  2020cites this paper
• TP53 R249S mutation detected in circulating tumour DNA is associated with Prognosis of hepatocellular carcinoma patients with or without hepatectomy

  2020cites this paper
• Myeloid signature reveals immune contexture and predicts the prognosis of hepatocellular carcinoma.

  2020cites this paper
• Recent developments and ongoing trials in transplant oncology

  2020cites this paper
• Accuracy of Milan, University of California San Francisco, and Up-To-7 Criteria in Predicting Tumor Recurrence Following Deceased-Donor Liver Transplant in Patients With Hepatocellular Carcinoma.

  2020cites this paper
• Multi-institutional Development and External Validation of a Nomogram Predicting Recurrence After Curative Liver Resection for Neuroendocrine Liver Metastasis

  2020cites this paper
• Genetics of Hepatocellular Carcinoma: Approaches to Explore Molecular Diversity

  2020cites this paper
• Pretreatment peripheral neutrophils, lymphocytes and monocytes predict long-term survival in hepatocellular carcinoma

  2020cites this paper
• RIGHT VENTRICULAR E/E’ RATIO INDEX FOR INTRAOPERATIVE ASSESSMENT OF RIGHT VENTRICULAR FILLING PRESSURE IN MITRAL VALVE SURGERIES WITH PULMONARY HYPERTENSION

  2020cites this paper
• Prognostic gene expression signature revealed the involvement of mutational pathways in cancer genome

  2020cites this paper
• A User-Friendly, Web-Based Integrative Tool (ESurv) for Survival Analysis: Development and Validation Study

  2020cites this paper
• FAM213A is linked to prognostic significance in acute myeloid leukemia through regulation of oxidative stress and myelopoiesis

  2020cites this paper
• Mutations and Genomic Alterations in Liver Cancer

  2020cites this paper
• Gross type of hepatocellular carcinoma reflects the tumor hypoxia, fibrosis, and stemness-related marker expression

  2020cites this paper
• Phenotypic Response and Personalized Medicine in Liver Cancer and Transplantation: Approaches to Complex Systems

  2020cites this paper
• Biomarkers for Hepatobiliary Cancers

  2020cites this paper
• Advances in molecular classification and precision oncology in hepatocellular carcinoma.

  2020cites this paper
• The Prediction of Survival in Hepatocellular Carcinoma Based on A Four Long Non-coding RNAs Expression Signature

  2020cites this paper
• Milestones in the pathogenesis and management of primary liver cancer.

  2020cites this paper
• Molecular docking, anti-proliferative activity and induction of apoptosis in human liver cancer cells treated with androstane derivatives: Implication of PI3K/AKT/mTOR pathway.

  2020cites this paper
• Charting the Path Forward for Risk Prediction in Liver Transplant for Hepatocellular Carcinoma: International Validation of HALTHCC Among 4,089 Patients

  2020cites this paper
• Hepatocyte ploidy and pathological mutations in hepatocellular carcinoma: impact on oncogenesis and therapeutics.

  2020cites this paper
• hsa_circ_0000092 promotes hepatocellular carcinoma progression through up‐regulating HN1 expression by binding to microRNA‐338‐3p

  2020cites this paper
• Prognostic evaluation of HCC patients undergoing surgical resection: an analysis of 8 different staging systems

  2020cites this paper
• Clinico-Radio-Pathological and Molecular Features of Hepatocellular Carcinomas with Keratin 19 Expression

  2020cites this paper
• Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma

  2020cites this paper
• HN1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by interacting with STMN1.

  2020cites this paper
• Identification and validation of the angiogenic genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma

  2020cites this paper
• Individualizing Care: Management Beyond Medical Therapy.

  2020cites this paper